Pharmaceutical companies by today's price change
How far the share price has moved since the previous close.
Spyre Therapeutics leads the 61 pharmaceutical companies ranked by today's price change, at +5.35%, ahead of TG Therapeutics (+5.11%) and Elanco Animal Health (+4.20%). Figures as of 18 Nov 2026, 19:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Spyre Therapeutics+5.35%
- Median
- -0.71%
- Combined market value
- SAR 19.02T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | +5.35% | SAR 35.2B | SAR 370.71 | 5.35% up | 286% up | ||
| 2 | TG TherapeuticsTGTX · Health Care | +5.11% | SAR 37.4B | SAR 247.25 | 5.11% up | 107% up | ||
| 3 | Elanco Animal HealthELAN · Health Care | +4.20% | SAR 50.5B | SAR 101.03 | 4.20% up | 20% up | ||
| 4 | Amneal PharmaceuticalsAMRX · Health Care | +4.12% | SAR 28.7B | SAR 82.48 | 4.12% up | 83% up | ||
| 5 | BioMarin PharmaceuticalBMRN · Health Care | +3.90% | SAR 44.2B | SAR 228.02 | 3.90% up | 11% up | ||
| 6 | Rhythm PharmaceuticalsRYTM · Health Care | +3.55% | SAR 31.4B | SAR 452.93 | 3.55% up | 13% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | +3.21% | SAR 17.4B | SAR 104.37 | 3.21% up | 64% down | ||
| 8 | AlkermesALKS · Health Care | +2.53% | SAR 29.4B | SAR 174.80 | 2.53% up | 58% up | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | +2.43% | SAR 59.4B | SAR 924.81 | 2.43% up | 37% up | ||
| 10 | ZoetisZTS · Health Care | +2.32% | SAR 130.2B | SAR 320.41 | 2.32% up | 29% down | ||
| 11 | Ligand PharmaceuticalsLGND · Health Care | +2.20% | SAR 22.5B | SAR 1,126.28 | 2.20% up | 43% up | ||
| 12 | ABIVAXABVX · Health Care | +1.88% | SAR 27.5B | SAR 313.75 | 1.88% up | 27% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.59% | SAR 47B | SAR 56.36 | 1.59% up | 5% up | ||
| 14 | BridgeBio PharmaBBIO · Health Care | +1.39% | SAR 56.9B | SAR 292.09 | 1.39% up | 17% up | ||
| 15 | Royalty PharmaRPRX · Health Care | +0.98% | SAR 149.6B | SAR 260.13 | 0.98% up | 78% up | ||
| 16 | ViatrisVTRS · Health Care | +0.90% | SAR 88.7B | SAR 77.40 | 0.90% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | +0.80% | SAR 512.1B | SAR 2,019.74 | 0.80% up | 27% up | ||
| 18 | Protagonist TherapeuticsPTGX · Health Care | +0.59% | SAR 30.7B | SAR 470.38 | 0.59% up | 46% up | ||
| 19 | Legend BiotechLEGN · Health Care | +0.50% | SAR 11.8B | SAR 60.73 | 0.50% up | 42% down | ||
| 20 | Cogent BiosciencesCOGT · Health Care | +0.41% | SAR 18.3B | SAR 104.90 | 0.41% up | 20% down | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | +0.34% | SAR 22.9B | SAR 161.80 | 0.34% up | 10% up | ||
| 22 | Praxis Precision MedicinesPRAX · Health Care | +0.17% | SAR 32B | SAR 1,146.21 | 0.17% up | 61% up | ||
| 23 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +0.05% | SAR 28B | SAR 356.95 | 0.05% up | 126% up | ||
| 24 | Abbott LaboratoriesABT · Health Care | -0.22% | SAR 678.8B | SAR 391.90 | 0.22% down | 17% down | ||
| 25 | PTC TherapeuticsPTCT · Health Care | -0.26% | SAR 18.9B | SAR 225.83 | 0.26% down | 20% down | ||
| 26 | Ascendis PharmaASND · Health Care | -0.33% | SAR 66.5B | SAR 1,013.91 | 0.33% down | 28% up | ||
| 27 | United TherapeuticsUTHR · Health Care | -0.48% | SAR 92.9B | SAR 2,180.42 | 0.48% down | 23% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | -0.55% | SAR 22.4B | SAR 342.99 | 0.55% down | 31% up | ||
| 29 | SanofiSNY · Health Care | -0.61% | SAR 425.5B | SAR 177.20 | 0.61% down | 4% down | ||
| 30 | Belite BioBLTE · Health Care | -0.64% | SAR 23.9B | SAR 587.80 | 0.64% down | 31% up | ||
| 31 | Dianthus TherapeuticsDNTH · Health Care | -0.71% | SAR 18.2B | SAR 323.94 | 0.71% down | 113% up | ||
| 32 | Roivant SciencesROIV · Health Care | -0.74% | SAR 104.4B | SAR 144.13 | 0.74% down | 90% up | ||
| 33 | Travere TherapeuticsTVTX · Health Care | -0.78% | SAR 18.3B | SAR 190.18 | 0.78% down | 44% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | -0.89% | SAR 31.7B | SAR 39.67 | 0.89% down | 36% down | ||
| 35 | Oruka TherapeuticsORKA · Health Care | -1.00% | SAR 24.3B | SAR 357.68 | 1.00% down | 241% up | ||
| 36 | Edgewise TherapeuticsEWTX · Health Care | -1.07% | SAR 17.1B | SAR 156.00 | 1.07% down | 88% up | ||
| 37 | CytokineticsCYTK · Health Care | -1.08% | SAR 26.7B | SAR 191.64 | 1.08% down | 20% down | ||
| 38 | VeradermicsMANE · Health Care | -1.15% | SAR 19.7B | SAR 465.87 | 1.15% down | 233% up | ||
| 39 | GenmabGMAB · Health Care | -1.15% | SAR 118.8B | SAR 192.65 | 1.15% down | 70% up | ||
| 40 | Teva Pharmaceutical IndustriesTEVA · Health Care | -1.23% | SAR 184.2B | SAR 157.90 | 1.23% down | 74% up | ||
| 41 | InsmedINSM · Health Care | -1.25% | SAR 99B | SAR 451.40 | 1.25% down | 40% down | ||
| 42 | GSKGSK · Health Care | -1.25% | SAR 365.6B | SAR 182.39 | 1.25% down | 6% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | -1.26% | SAR 367B | SAR 3,547.45 | 1.26% down | 36% up | ||
| 44 | PfizerPFE · Health Care | -1.36% | SAR 600.4B | SAR 105.33 | 1.36% down | 14% up | ||
| 45 | Takeda PharmaceuticalTAK · Health Care | -1.39% | SAR 255.7B | SAR 80.05 | 1.39% down | 54% up | ||
| 46 | Axsome TherapeuticsAXSM · Health Care | -1.43% | SAR 26.4B | SAR 502.63 | 1.43% down | 7% down | ||
| 47 | Johnson & JohnsonJNJ · Health Care | -1.71% | SAR 2.47T | SAR 1,027.55 | 1.71% down | 38% up | ||
| 48 | AstraZenecaAZN · Health Care | -1.81% | SAR 1.04T | SAR 671.30 | 1.81% down | 2% up | ||
| 49 | Eli LillyLLY · Health Care | -1.89% | SAR 4.64T | SAR 5,209.60 | 1.89% down | 35% up | ||
| 50 | AbbVieABBV · Health Care | -2.12% | SAR 1.9T | SAR 1,075.13 | 2.12% down | 26% up | ||
| 51 | BeOne MedicinesONC · Health Care | -2.13% | SAR 173.3B | SAR 1,517.13 | 2.13% down | 17% up | ||
| 52 | NovartisNVS · Health Care | -2.26% | SAR 1.1T | SAR 583.43 | 2.26% down | 25% up | ||
| 53 | GrifolsGRFS · Health Care | -2.26% | SAR 21.5B | SAR 31.64 | 2.26% down | 1% up | ||
| 54 | Bristol-Myers SquibbBMY · Health Care | -2.37% | SAR 459.2B | SAR 224.67 | 2.37% down | 34% up | ||
| 55 | Definium TherapeuticsDFTX · Health Care | -2.65% | SAR 14.7B | SAR 107.28 | 2.65% down | 169% up | ||
| 56 | Novo NordiskNVO · Health Care | -2.86% | SAR 653.6B | SAR 148.30 | 2.86% down | 17% down | ||
| 57 | Corcept TherapeuticsCORT · Health Care | -3.30% | SAR 27.8B | SAR 254.17 | 3.30% down | 8% down | ||
| 58 | ErascaERAS · Health Care | -3.53% | SAR 17.6B | SAR 50.26 | 3.53% down | 403% up | ||
| 59 | Merck & CoMRK · Health Care | -4.10% | SAR 1.27T | SAR 515.74 | 4.10% down | 51% up | ||
| 60 | Alnylam PharmaceuticalsALNY · Health Care | -4.39% | SAR 75.2B | SAR 561.28 | 4.39% down | 66% down | ||
| 61 | Madrigal PharmaceuticalsMDGL · Health Care | -5.06% | SAR 34.9B | SAR 1,502.75 | 5.06% down | 24% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceutical companies rank first by today's price change?
Spyre Therapeutics (+5.35%), TG Therapeutics (+5.11%) and Elanco Animal Health (+4.20%) are the top three of the 61 pharmaceutical companies ranked by today's price change as of 18 Nov 2026, 19:17 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by today's price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by today's price change have a combined market value of SAR 19.02T as of 18 Nov 2026, 19:17 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.